EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

The Effect of a Low-FODMAP Diet on Quality of Life, Severity of Symptoms and Leaky Gut in Patients with Irritable Bowel Syndrome

Esra Demir, Yunus Can Ozalp iD, Hasan Basri Ergun iD, Burcu Uludag, Oktay Olmuşçelik iD, Gozde Ulfer, Omar Alomari iD

Nutrients · 2026

DOI: 10.3390/nu18142371 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2026. Verfasst von Esra Demir und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Istanbul Medipol University, 34810 Istanbul, Türkiye. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Quality of Life, FODMAP Diet. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Istanbul Medipol University, Istanbul Medipol University Scientific Research Projects Coordination Unit.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We aimed to investigate the effects of a low-FODMAP (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols) diet on symptom severity, quality of life, and fecal zonulin levels in patients with irritable bowel syndrome (IBS).

Methods

Twenty-four patients with IBS were prospectively randomized to either a low-FODMAP diet (LFD) or a traditional diet (TD) for 4 weeks. IBS Symptom Severity Scale (IBS-SSS), IBS Quality of Life (IBS-QOL), and fecal zonulin levels were assessed at baseline and week 4 in both groups. In the LFD group, FODMAP-containing foods were gradually reintroduced after week 4, and all assessments were repeated at week 16. Changes in laboratory parameters, fecal zonulin levels, IBS-SSS, and IBS-QOL scores were evaluated.

Results

Fecal zonulin levels did not differ significantly between groups at baseline or week 4, and no significant within-group changes were observed over time (all p > 0.05). IBS-SSS scores improved significantly at week 4 in both groups compared with the baseline (p < 0.05), with no significant difference in the magnitude of improvement between groups (p > 0.05). In the LFD group, IBS-SSS scores increased at week 16 compared with week 4 (p < 0.05). Similarly, IBS-QOL scores improved significantly at week 4 in both groups (p < 0.05), without significant between-group differences (p > 0.05). In the LFD group, IBS-QOL scores returned to baseline levels by week 16.

Conclusions

Both the LFD and TD were associated with significant short-term improvements in IBS symptom severity and quality of life. However, the LFD did not demonstrate superiority over the TD. Furthermore, no statistically significant changes in fecal zonulin levels were observed in either group, although these findings should be interpreted cautiously. In the LFD group, some improvements observed at week 4 were attenuated following FODMAP reintroduction at week 16; however, these findings represent exploratory within-group observations and should not be interpreted as evidence of long-term treatment efficacy or sustained benefit following FODMAP reintroduction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Irritable Bowel SyndromeQuality of LifeFODMAP DietHumansFemaleMaleFecesHaptoglobinsProtein PrecursorsSeverity of Illness IndexAdultMiddle AgedCholera ToxinProspective StudiesTreatment OutcomeIntestinal Barrier FunctionOligosaccharides

Stichwörter der Autor:innen

Low-FODMAP dietirritable bowel syndromeleaky gut

Substanzen

HaptoglobinsProtein PrecursorszonulinCholera ToxinOligosaccharides

Autor:innen und Institutionen

  • Department of Internal Medicine, Istanbul Medipol University, 34810 Istanbul, Türkiye.
  • Department of Nutrition and Dietetics, Istanbul Medipol University, 34810 Istanbul, Türkiye.
  • Department of Medical Biochemistry, Istanbul Medipol University, 34810 Istanbul, Türkiye.
  • Hamidiye International School of Medicine, University of Health Sciences, 34668 Istanbul, Türkiye.

ORCID-Profile: Yunus Can Ozalp, Hasan Basri Ergun, Oktay Olmuşçelik, Omar Alomari

Förderung

  • Istanbul Medipol University
  • Istanbul Medipol University Scientific Research Projects Coordination Unit

Zitieren

APA

Demir, E., Ozalp, Y. C., Ergun, H. B., Uludag, B., Olmuşçelik, O., Ulfer, G., & Alomari, O. (2026). The Effect of a Low-FODMAP Diet on Quality of Life, Severity of Symptoms and Leaky Gut in Patients with Irritable Bowel Syndrome. Nutrients. https://doi.org/10.3390/nu18142371

Vancouver

Demir E, Ozalp YC, Ergun HB, Uludag B, Olmuşçelik O, Ulfer G, et al. The Effect of a Low-FODMAP Diet on Quality of Life, Severity of Symptoms and Leaky Gut in Patients with Irritable Bowel Syndrome. Nutrients. 2026. doi:10.3390/nu18142371

BibTeX
@article{Demir2026,
  author = {Demir, Esra and Ozalp, Yunus Can and Ergun, Hasan Basri and Uludag, Burcu and Olmuşçelik, Oktay and Ulfer, Gozde and Alomari, Omar},
  title = {The Effect of a Low-FODMAP Diet on Quality of Life, Severity of Symptoms and Leaky Gut in Patients with Irritable Bowel Syndrome},
  journal = {Nutrients},
  year = {2026},
  doi = {10.3390/nu18142371}
}
Kostenlos starten →